KEGG   PATHWAY: prob04931
Entry
prob04931                   Pathway                                
Name
Insulin resistance - Phodopus roborovskii (desert hamster)
Description
Insulin resistance is a condition where cells become resistant to the effects of insulin. It is often found in people with health disorders, including obesity, type 2 diabetes mellitus, non-alcoholic fatty liver disease, and cardiovascular diseases. In this diagram multiple mechanisms underlying insulin resistance are shown: (a) increased phosphorylation of IRS (insulin receptor substrate) protein through serine/threonine kinases, such as JNK1 and IKKB, and protein kinase C, (b) increased IRS-1 proteasome degradation via mTOR signaling pathway, (c) decreased activation of signaling molecules including PI3K and AKT, (d) increase in activity of phosphatases including PTPs, PTEN, and PP2A. Regulatory actions such as oxidative stress, mitochondrial dysfunction, accumulation of intracellular lipid derivatives (diacylglycrol and ceramides), and inflammation (via IL-6 and TNFA) contribute to these mechanisms. Consequently, insulin resistance causes reduced GLUT4 translocation, resulting in glucose takeup and glycogen synthesis in skeletal muscle as well as increased hepatic gluconeogenesis and decreased glycogen synthesis in liver. At the bottom of the diagram, interplay between O-GlcNAcylation and serine/threonine phosphorylation is shown. Studies suggested that elevated O-GlcNAc level was correlated to high glucose-induced insulin resistance. Donor UDP-GlcNAc is induced through hexosamine biosynthesis pathway and added to proteins by O-GlcNAc transferase. Elevation of O-GlcNAc modification alters phosphorylation and function of key insulin signaling proteins including IRS-1, PI3K, PDK1, Akt and other transcription factor and cofactors, resulting in the attenuation of insulin signaling cascade.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
prob04931  Insulin resistance
prob04931

Organism
Phodopus roborovskii (desert hamster) [GN:prob]
Gene
127216119  Rps6ka3; ribosomal protein S6 kinase alpha-3 isoform X1 [KO:K04373] [EC:2.7.11.1]
127237637  Rps6ka2; ribosomal protein S6 kinase alpha-2 isoform X1 [KO:K04373] [EC:2.7.11.1]
127213392  Rps6ka1; ribosomal protein S6 kinase alpha-1 isoform X1 [KO:K04373] [EC:2.7.11.1]
127226602  Rps6ka6; ribosomal protein S6 kinase alpha-6 [KO:K04373] [EC:2.7.11.1]
127216061  Ppp1cc; serine/threonine-protein phosphatase PP1-gamma catalytic subunit [KO:K06269] [EC:3.1.3.16]
127228640  Ppp1ca; serine/threonine-protein phosphatase PP1-alpha catalytic subunit [KO:K06269] [EC:3.1.3.16]
127220109  Ppp1cb; serine/threonine-protein phosphatase PP1-beta catalytic subunit [KO:K06269] [EC:3.1.3.16]
127222756  Ppp1r3d; protein phosphatase 1 regulatory subunit 3D [KO:K07189]
127230404  Ppp1r3e; protein phosphatase 1 regulatory subunit 3E [KO:K07189]
127220423  Ppp1r3b; protein phosphatase 1 regulatory subunit 3B [KO:K07189]
127233220  Ppp1r3c; protein phosphatase 1 regulatory subunit 3C [KO:K07189]
127215329  Ppp1r3a; protein phosphatase 1 regulatory subunit 3A isoform X1 [KO:K07189]
127237189  Insr; insulin receptor isoform X1 [KO:K04527] [EC:2.7.10.1]
127226500  Irs1; insulin receptor substrate 1 [KO:K16172]
127223333  Ptpn1; tyrosine-protein phosphatase non-receptor type 1 isoform X1 [KO:K05696] [EC:3.1.3.48]
127216041  Ptpn11; tyrosine-protein phosphatase non-receptor type 11 isoform X1 [KO:K07293] [EC:3.1.3.48]
127225248  Ptprf; receptor-type tyrosine-protein phosphatase F isoform X1 [KO:K05695] [EC:3.1.3.48]
127223328  Pik3ca; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
127238024  Pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
127213428  Pik3cd; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
127217216  Pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
127225197  Pik3r3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
127220972  Pik3r1; phosphatidylinositol 3-kinase regulatory subunit alpha [KO:K02649]
127223664  Akt3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
127231187  Akt1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
127239025  Akt2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
127213510  Mtor; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
127228636  Rps6kb2; ribosomal protein S6 kinase beta-2 [KO:K04688] [EC:2.7.11.1]
127224001  Rps6kb1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
127228289  Prkcb; protein kinase C beta type [KO:K19662] [EC:2.7.11.13]
127235558  Il6; interleukin-6 [KO:K05405]
127216384  Stat3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
127219795  Socs3; suppressor of cytokine signaling 3 [KO:K04696]
127227159  Gsk3b; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
127215592  LOW QUALITY PROTEIN: glycogen [starch] synthase, liver-like [KO:K00693] [EC:2.4.1.11]
127213091  Gys2; glycogen [starch] synthase, liver [KO:K00693] [EC:2.4.1.11]
127213697  Gys1; glycogen [starch] synthase, muscle [KO:K00693] [EC:2.4.1.11]
127224347  Tnf; tumor necrosis factor [KO:K03156]
127213032  Tnfrsf1a; tumor necrosis factor receptor superfamily member 1A [KO:K03158]
127235390  Mapk8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
127219360  Mapk9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
127232178  Mapk10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
127220313  Ikbkb; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
127230598  Nfkbia; NF-kappa-B inhibitor alpha [KO:K04734]
127222971  Nfkb1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
127228707  Rela; transcription factor p65 isoform X1 [KO:K04735]
127235683  Nos3; nitric oxide synthase, endothelial [KO:K13242] [EC:1.14.13.39]
127213543  Prkcz; protein kinase C zeta type [KO:K18952] [EC:2.7.11.13]
127230130  Tbc1d4; TBC1 domain family member 4 [KO:K17902]
127219033  Slc2a4; solute carrier family 2, facilitated glucose transporter member 4 [KO:K07191]
127224997  Prkaa2; 5'-AMP-activated protein kinase catalytic subunit alpha-2 [KO:K07198] [EC:2.7.11.31]
127220610  Prkaa1; 5'-AMP-activated protein kinase catalytic subunit alpha-1 [KO:K07198] [EC:2.7.11.31]
127216002  Prkab1; 5'-AMP-activated protein kinase subunit beta-1 [KO:K07199]
127233006  Prkab2; 5'-AMP-activated protein kinase subunit beta-2 isoform X1 [KO:K07199]
127235796  Prkag2; 5'-AMP-activated protein kinase subunit gamma-2 isoform X1 [KO:K07200]
127226041  Prkag1; 5'-AMP-activated protein kinase subunit gamma-1 [KO:K07200]
127226445  Prkag3; 5'-AMP-activated protein kinase subunit gamma-3 [KO:K07200]
127215967  Acacb; acetyl-CoA carboxylase 2 [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
127225959  Cpt1b; carnitine O-palmitoyltransferase 1, muscle isoform [KO:K19523] [EC:2.3.1.21]
127234572  Agt; angiotensinogen [KO:K09821]
127222696  Slc27a4; long-chain fatty acid transport protein 4 [KO:K08745] [EC:6.2.1.-]
127217230  Slc27a1; long-chain fatty acid transport protein 1 [KO:K08745] [EC:6.2.1.-]
127221509  Slc27a2; long-chain fatty acid transport protein 2 [KO:K08746] [EC:6.2.1.- 6.2.1.3]
127232591  Slc27a3; long-chain fatty acid transport protein 3 [KO:K08772] [EC:6.2.1.-]
127238975  Slc27a5; long-chain fatty acid transport protein 5 [KO:K08748] [EC:6.2.1.7]
127234175  Slc27a6; long-chain fatty acid transport protein 6 [KO:K08749]
127214375  Cd36; platelet glycoprotein 4 [KO:K06259]
127229821  Prkcq; protein kinase C theta type isoform X1 [KO:K18052] [EC:2.7.11.13]
127236861  Prkcd; protein kinase C delta type [KO:K06068] [EC:2.7.11.13]
127222724  Ptpa; serine/threonine-protein phosphatase 2A activator isoform X1 [KO:K17605]
127219200  Srebf1; sterol regulatory element-binding protein 1 isoform X1 [KO:K07197]
127220248  Irs2; insulin receptor substrate 2 [KO:K07187]
127228506  Trib3; tribbles homolog 3 isoform X1 [KO:K19518]
127228731  Pygm; glycogen phosphorylase, muscle form isoform X1 [KO:K00688] [EC:2.4.1.1]
127228866  Pygb; glycogen phosphorylase, brain form [KO:K00688] [EC:2.4.1.1]
127230657  Pygl; glycogen phosphorylase, liver form [KO:K00688] [EC:2.4.1.1]
127216298  Foxo1; forkhead box protein O1 [KO:K07201]
127222798  Pck1; phosphoenolpyruvate carboxykinase, cytosolic [GTP] [KO:K01596] [EC:4.1.1.32]
127230385  Pck2; phosphoenolpyruvate carboxykinase [GTP], mitochondrial [KO:K01596] [EC:4.1.1.32]
127221880  G6pc2; glucose-6-phosphatase 2 [KO:K01084] [EC:3.1.3.9]
127216693  G6pc1; glucose-6-phosphatase catalytic subunit 1 [KO:K01084] [EC:3.1.3.9]
127217401  G6pc3; glucose-6-phosphatase 3 [KO:K01084] [EC:3.1.3.9]
127223358  Slc2a2; solute carrier family 2, facilitated glucose transporter member 2 [KO:K07593]
127222250  Nr1h3; oxysterols receptor LXR-alpha isoform X1 [KO:K08536]
127213715  Nr1h2; oxysterols receptor LXR-beta isoform X1 [KO:K08535]
127234067  Ppargc1b; peroxisome proliferator-activated receptor gamma coactivator 1-beta isoform X1 [KO:K17962]
127216092  Mlxip; MLX-interacting protein [KO:K09113]
127216474  Mlx; max-like protein X isoform X1 [KO:K09113]
127236884  Mlxipl; carbohydrate-responsive element-binding protein isoform X1 [KO:K09113]
127228604  Cpt1a; carnitine O-palmitoyltransferase 1, liver isoform [KO:K08765] [EC:2.3.1.21]
127214920  Prkce; protein kinase C epsilon type isoform X1 [KO:K18050] [EC:2.7.11.13]
127213598  Ppargc1a; peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X1 [KO:K07202]
127225913  Ppara; peroxisome proliferator-activated receptor alpha [KO:K07294]
127219578  Pdpk1; 3-phosphoinositide-dependent protein kinase 1 isoform X1 [KO:K06276] [EC:2.7.11.1]
127233551  Pten; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
127233458  Oga; protein O-GlcNAcase isoform X1 [KO:K15719] [EC:3.2.1.169 2.3.1.48]
127218142  Ogt; UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X1 [KO:K09667] [EC:2.4.1.255]
127225264  Slc2a1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
127236028  Gfpt1; glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 isoform X1 [KO:K00820] [EC:2.6.1.16]
127219361  Gfpt2; glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 [KO:K00820] [EC:2.6.1.16]
127232977  Crtc2; CREB-regulated transcription coactivator 2 isoform X1 [KO:K16333]
127226375  Creb1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870]
127222230  Creb3l1; cyclic AMP-responsive element-binding protein 3-like protein 1 isoform X1 [KO:K09048]
127216557  Creb3l3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048]
127217490  cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048]
127224594  Creb3; cyclic AMP-responsive element-binding protein 3 [KO:K09048]
127232866  Creb3l4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048]
127214253  Creb3l2; cyclic AMP-responsive element-binding protein 3-like protein 2 isoform X1 [KO:K09048]
127235522  Creb5; LOW QUALITY PROTEIN: cyclic AMP-responsive element-binding protein 5 [KO:K09047]
Compound
C00022  Pyruvate
C00024  Acetyl-CoA
C00031  D-Glucose
C00043  UDP-N-acetyl-alpha-D-glucosamine
C00083  Malonyl-CoA
C00085  D-Fructose 6-phosphate
C00092  D-Glucose 6-phosphate
C00095  D-Fructose
C00162  Fatty acid
C00165  Diacylglycerol
C00195  N-Acylsphingosine
C00352  D-Glucosamine 6-phosphate
C00369  Starch
C00422  Triacylglycerol
C00533  Nitric oxide
C02571  O-Acetylcarnitine
C02843  Long-chain acyl-CoA
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C06156  alpha-D-Glucosamine 1-phosphate
G00369   
Reference
  Authors
Martins AR, Nachbar RT, Gorjao R, Vinolo MA, Festuccia WT, Lambertucci RH, Cury-Boaventura MF, Silveira LR, Curi R, Hirabara SM
  Title
Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function.
  Journal
Lipids Health Dis 11:30 (2012)
DOI:10.1186/1476-511X-11-30
Reference
  Authors
Bouzakri K, Roques M, Gual P, Espinosa S, Guebre-Egziabher F, Riou JP, Laville M, Le Marchand-Brustel Y, Tanti JF, Vidal H
  Title
Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes.
  Journal
Diabetes 52:1319-25 (2003)
DOI:10.2337/diabetes.52.6.1319
Reference
  Authors
Choi K, Kim YB
  Title
Molecular mechanism of insulin resistance in obesity and type 2 diabetes.
  Journal
Korean J Intern Med 25:119-29 (2010)
DOI:10.3904/kjim.2010.25.2.119
Reference
PMID:7666792
  Authors
Ahmad F, Goldstein BJ
  Title
Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.
  Journal
Metabolism 44:1175-84 (1995)
DOI:10.1016/0026-0495(95)90012-8
Reference
  Authors
George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PR, Williams RM, Acerini CL, Dunger DB, Barford D, Umpleby AM, Wareham NJ, Davies HA, Schafer AJ, Stoffel M, O'Rahilly S, Barroso I
  Title
A family with severe insulin resistance and diabetes due to a mutation in AKT2.
  Journal
Science 304:1325-8 (2004)
DOI:10.1126/science.1096706
Reference
  Authors
Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM
  Title
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions.
  Journal
Int J Endocrinol 2012:983814 (2012)
DOI:10.1155/2012/983814
Reference
  Authors
Morino K, Petersen KF, Shulman GI
  Title
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.
  Journal
Diabetes 55 Suppl 2:S9-S15 (2006)
DOI:10.2337/db06-S002
Reference
  Authors
Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK
  Title
Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.
  Journal
Diabetes 54:2939-45 (2005)
DOI:10.2337/diabetes.54.10.2939
Reference
  Authors
Kim JA, Wei Y, Sowers JR
  Title
Role of mitochondrial dysfunction in insulin resistance.
  Journal
Circ Res 102:401-14 (2008)
DOI:10.1161/CIRCRESAHA.107.165472
Reference
  Authors
Steinberg GR, Michell BJ, van Denderen BJ, Watt MJ, Carey AL, Fam BC, Andrikopoulos S, Proietto J, Gorgun CZ, Carling D, Hotamisligil GS, Febbraio MA, Kay TW, Kemp BE
  Title
Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling.
  Journal
Cell Metab 4:465-74 (2006)
DOI:10.1016/j.cmet.2006.11.005
Reference
PMID:9886945
  Authors
Ruderman NB, Saha AK, Vavvas D, Witters LA
  Title
Malonyl-CoA, fuel sensing, and insulin resistance.
  Journal
Am J Physiol 276:E1-E18 (1999)
DOI:10.1152/ajpendo.1999.276.1.E1
Reference
PMID:8048519
  Authors
Saha AK, Kurowski TG, Colca JR, Ruderman NB
  Title
Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol.
  Journal
Am J Physiol 267:E95-101 (1994)
DOI:10.1152/ajpendo.1994.267.1.E95
Reference
  Authors
Blachnio-Zabielska AU, Koutsari C, Tchkonia T, Jensen MD
  Title
Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance.
  Journal
Obesity (Silver Spring) 20:2341-7 (2012)
DOI:10.1038/oby.2012.126
Reference
  Authors
Larter CZ, Farrell GC
  Title
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
  Journal
J Hepatol 44:253-61 (2006)
DOI:10.1016/j.jhep.2005.11.030
Reference
  Authors
Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M
  Title
PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.
  Journal
Nat Med 10:530-4 (2004)
DOI:10.1038/nm1044
Reference
  Authors
Slawson C, Copeland RJ, Hart GW
  Title
O-GlcNAc signaling: a metabolic link between diabetes and cancer?
  Journal
Trends Biochem Sci 35:547-55 (2010)
DOI:10.1016/j.tibs.2010.04.005
Reference
  Authors
Ruan HB, Singh JP, Li MD, Wu J, Yang X
  Title
Cracking the O-GlcNAc code in metabolism.
  Journal
Trends Endocrinol Metab 24:301-9 (2013)
DOI:10.1016/j.tem.2013.02.002
Reference
  Authors
Muoio DM, Newgard CB
  Title
Obesity-related derangements in metabolic regulation.
  Journal
Annu Rev Biochem 75:367-401 (2006)
DOI:10.1146/annurev.biochem.75.103004.142512
Reference
  Authors
Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL
  Title
Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity.
  Journal
Diabetes 49:1353-8 (2000)
DOI:10.2337/diabetes.49.8.1353
Related
pathway
prob00010  Glycolysis / Gluconeogenesis
prob00061  Fatty acid biosynthesis
prob00514  Other types of O-glycan biosynthesis
prob00520  Amino sugar and nucleotide sugar metabolism
prob04150  mTOR signaling pathway
prob04151  PI3K-Akt signaling pathway
prob04668  TNF signaling pathway
prob04910  Insulin signaling pathway
KO pathway
ko04931   
LinkDB

DBGET integrated database retrieval system